Syntagon Technical Director to host presentation at CPhI Worldwide

​Leading contract research organisation, Syntagon, is to deliver a presentation at one of the pharma industry’s highest profile events, CPhI Worldwide, being held this October in Paris, France. Syntagon’s Technical Director, Dr Anders Högdin, will give a talk entitled ‘Compound to Clinic – Drug Development Dos and Don’ts’. 

“Based on Syntagon’s extensive experience of supporting over 150 companies successfully launch clinical trials, the presentation seeks to offer pragmatic advice and recommendations on key aspects of the drug development process,” says Högdin.

“Syntagon is an excellent match for companies that tend to have less experience of navigating their compound through regulatory and technical requirements to clinical trials,” Högdin adds.

Boasting more than 1,800 exhibitors and in excess of 25,000 participants from more than 125 countries, CPhI Worldwide is the largest event in the pharma industry. This year, CPhI will take place in Paris and run between October 5 and 7. First held in 1990, when just 16 exhibitors drew 250 visitors, CPhI has grown rapidly to become an event of unrivalled importance for the industry.

The presentation will be held on the second day of CPhI – October 6 – at ‘Speaker’s Corner’ in Hall 4 at 11 AM.

For further details on this press release, please contact John Cameron, Syntagon Director of Sales & Marketing Europe at john.cameron@syntagon.se.

Syntagon is a leading Scandinavia-based drug development partner. We develop compounds from lead optimisation to Phase II clinical trials using the latest technology and equipment combined with a solid quality system. For more about Syntagon, visit our website at www.syntagon.com, and follow us on Twitter at http://twitter.com/Syntagon.

Tags: